Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) announces a share repurchase program. Under the program, the company will repurchase up to CNY 500 million worth of class A shares. The shares will be repurchased at a maximum price of CNY 190 per share. The program will be funded by self-owned funds or self-raised funds. The shares will be used to implement the A share equity incentive scheme or A share employee stock ownership plan. The program is valid for 12 months from the date of approval of the board or end prematurely from the date on which a resolution to terminate to the share repurchase plan is passed by the Board.